These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 31531092)

  • 1. Supply Chain Challenges in Pharmaceutical Manufacturing Companies: Using Qualitative System Dynamics Methodology.
    Moosivand A; Rajabzadeh Ghatari A; Rasekh HR
    Iran J Pharm Res; 2019; 18(2):1103-1116. PubMed ID: 31531092
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Strategies to improve pharmaceutical supply chain resilience under politico-economic sanctions: the case of Iran.
    Bastani P; Dehghan Z; Kashfi SM; Dorosti H; Mohammadpour M; Mehralian G; Ravangard R
    J Pharm Policy Pract; 2021 Jul; 14(1):56. PubMed ID: 34225794
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Challenge of Politico-Economic Sanctions on Pharmaceutical Procurement in Iran: A Qualitative Study.
    Bastani P; Dehghan Z; Kashfi SM; Dorosti H; Mohammadpour M; Mehralian G
    Iran J Med Sci; 2022 Mar; 47(2):152-161. PubMed ID: 35291429
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An application of multi-criteria decision-making approach to sustainable drug shortages management: evidence from a developing country.
    Moosivand A; Rangchian M; Zarei L; Peiravian F; Mehralian G; Sharifnia H
    J Pharm Health Care Sci; 2021 Apr; 7(1):14. PubMed ID: 33795021
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Developing a suitable model for supplier selection based on supply chain risks: an empirical study from Iranian pharmaceutical companies.
    Mehralian G; Rajabzadeh Gatari A; Morakabati M; Vatanpour H
    Iran J Pharm Res; 2012; 11(1):209-19. PubMed ID: 24250442
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Critical Success Factors of a Drug Traceability System for Creating Value in a Pharmaceutical Supply Chain (PSC).
    Silva RBD; Mattos CA
    Int J Environ Res Public Health; 2019 Jun; 16(11):. PubMed ID: 31167350
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Developing a model for agile supply: an empirical study from Iranian pharmaceutical supply chain.
    Rajabzadeh Ghatari A; Mehralian G; Zarenezhad F; Rasekh HR
    Iran J Pharm Res; 2013; 12(Suppl):193-205. PubMed ID: 24250689
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Challenges of implementation: Strategic purchasing in Iran Health Insurance Organization.
    Kalantari AR; Jafari Sirizi M; Mehrolhassani MH; Dehnavieh R
    Int J Health Plann Manage; 2019 Jan; 34(1):e875-e884. PubMed ID: 30408235
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Information flow in the pharmaceutical supply chain.
    Yousefi N; Alibabaei A
    Iran J Pharm Res; 2015; 14(4):1299-303. PubMed ID: 26664401
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Challenges for food security and safety: a qualitative study in an agriculture supply chain company in Iran.
    Sadati AK; Nayedar M; Zartash L; Falakodin Z
    Agric Food Secur; 2021; 10(1):41. PubMed ID: 34642601
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Future supply chains enabled by continuous processing--opportunities and challenges. May 20-21, 2014 Continuous Manufacturing Symposium.
    Srai JS; Badman C; Krumme M; Futran M; Johnston C
    J Pharm Sci; 2015 Mar; 104(3):840-9. PubMed ID: 25631279
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reducing stock-outs of essential tuberculosis medicines: a system dynamics modelling approach to supply chain management.
    Bam L; McLaren ZM; Coetzee E; von Leipzig KH
    Health Policy Plan; 2017 Oct; 32(8):1127-1134. PubMed ID: 28541542
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mediating Role of Green Supply Chain Management Between Lean Manufacturing Practices and Sustainable Performance.
    Awan FH; Dunnan L; Jamil K; Mustafa S; Atif M; Gul RF; Guangyu Q
    Front Psychol; 2021; 12():810504. PubMed ID: 35046878
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmaceutical supply chain risk assessment in Iran using analytic hierarchy process (AHP) and simple additive weighting (SAW) methods.
    Jaberidoost M; Olfat L; Hosseini A; Kebriaeezadeh A; Abdollahi M; Alaeddini M; Dinarvand R
    J Pharm Policy Pract; 2015; 8(1):9. PubMed ID: 25838919
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of Patent Expiry on the Performance of Innovator Multinational Pharmaceutical Companies in a Low Middle Income Country.
    Khalil F; Onyango JO
    Front Med Technol; 2022; 4():783460. PubMed ID: 35445207
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The triple-A supply chain.
    Lee HL
    Harv Bus Rev; 2004 Oct; 82(10):102-12, 157. PubMed ID: 15559579
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sustainable Supply Chain Strategy and Sustainable Competitive Advantage: A Mediated and Moderated Model.
    Sun J; Sarfraz M; Khawaja KF; Abdullah MI
    Front Public Health; 2022; 10():895482. PubMed ID: 35664096
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Six Sigma: not for the faint of heart.
    Benedetto AR
    Radiol Manage; 2003; 25(2):40-53. PubMed ID: 12800564
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Integration vs Collaborative Redesign Strategies of Health Systems' Supply Chains in the Post-COVID-19 New Normal: Cross-sectional Survey Across the United States.
    Khuntia J; Mejia FJ; Ning X; Helton J; Stacey R
    JMIR Form Res; 2022 Jun; 6(6):e35317. PubMed ID: 35452405
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.